The Hidden Marker: Why Fasting Insulin Predicts Metabolic Health Better Than HbA1c

# The Hidden Marker: Why Fasting Insulin Predicts Metabolic Health Better Than HbA1c

Overview

For decades, the global medical establishment has relied upon a singular metric to define the boundaries of metabolic health: blood glucose. Whether through a simple finger-prick test or the more sophisticated HbA1c (Glycated Haemoglobin) laboratory assay, the focus has remained stubbornly fixed on the sugar circulating in the stream, rather than the hormonal driver controlling it. At INNERSTANDING, we recognise this as a fundamental diagnostic failure—a systemic oversight that allows millions of individuals to drift toward chronic disease while being told their "results are normal."

The biological reality is that blood glucose is a "lagging indicator." It is the final domino to fall in a sequence of metabolic collapse that often begins ten to fifteen years earlier. By the time an individual’s HbA1c rises into the pre-diabetic or diabetic range, the underlying machinery of their metabolism has been grinding under immense strain for over a decade. The "Hidden Marker" that the mainstream narrative continues to ignore is Fasting Insulin.

While glucose represents the fuel, insulin represents the effort required to manage that fuel. Measuring glucose without insulin is like looking at a car’s speedometer while ignoring the tachometer; you may be travelling at a safe 30mph, but if your engine is red-lining at 8,000 RPM to maintain that speed, a catastrophic breakdown is imminent. To truly understand metabolic health, we must shift our gaze to Hyperinsulinaemia—the state of chronically elevated insulin—and the HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) index. This article will expose the cellular mechanisms of this "silent" progression and provide the biological roadmap required to reclaim metabolic sovereignty.

##

The Biology — How It Works

To grasp why fasting insulin is the superior metric, one must first understand the hierarchy of fuel management within the human body. The body views elevated blood glucose as a direct threat; if left unchecked, glucose causes glycation—the non-enzymatic bonding of sugar molecules to proteins and lipids, essentially "caramelising" tissues and causing systemic inflammation. To prevent this, the pancreas, specifically the Beta cells in the Islets of Langerhans, secretes insulin.

The Myth of HbA1c

HbA1c measures the percentage of red blood cells that have become glycated over a three-month period. While useful for monitoring long-term sugar exposure, it is a flawed diagnostic tool for early-stage metabolic dysfunction. This is because the body will prioritise blood glucose stability at almost any cost. Even as a person develops Insulin Resistance, the pancreas simply compensates by pumping out exponentially more insulin.

In this compensatory phase, a patient’s blood sugar remains "perfect" because their insulin is "heroic." A standard NHS blood panel will show a blood glucose of 5.0 mmol/L and an HbA1c of 5.2%, and the GP will offer a clean bill of health. However, that same patient may have a fasting insulin level of 25 µU/mL—five times higher than the optimal range. This individual is metabolically crumbling, yet the system is blind to it because it only measures the sugar, not the hormone.

The Role of the Liver and Adipose Tissue

Insulin is an anabolic (storage) hormone. Its primary role is to signal the liver, muscles, and fat cells to take up glucose. In a healthy state, the liver stores glucose as glycogen. Once glycogen stores are full, insulin triggers De Novo Lipogenesis (DNL)—the process of converting excess sugar into palmitic acid (fat). This fat is then exported as Very Low-Density Lipoprotein (VLDL) to be stored in adipose tissue.

The "Personal Fat Threshold" is a critical biological concept here. Every individual has a genetically determined capacity to store subcutaneous fat. Once this threshold is breached, fat begins to "spill over" into places it doesn't belong—the liver, the pancreas, and the skeletal muscle. This ectopic fat is the primary driver of insulin resistance, creating a feedback loop where more insulin is required to achieve the same metabolic result.

##

Mechanisms at the Cellular Level

At the heart of this crisis is the Insulin Receptor, a complex trans-membrane protein that acts as the "lock" for the insulin "key." When insulin binds to the alpha subunits of the receptor, it triggers a cascade of intracellular events known as the PI3K/Akt pathway.

The GLUT4 Translocation

The ultimate goal of insulin signalling in muscle and fat cells is the movement of GLUT4 (Glucose Transporter Type 4) vesicles from the interior of the cell to the plasma membrane. Once at the surface, these transporters act as "gates" that allow glucose to enter the cell via facilitated diffusion.

In a state of insulin resistance, this signalling pathway is sabotaged. The primary culprit is Serine Phosphorylation of the Insulin Receptor Substrate 1 (IRS-1). Under normal conditions, IRS-1 is phosphorylated on tyrosine residues to transmit the signal. However, when the cell is "overfull" (due to excess fatty acids and oxidative stress), specific enzymes like Jun N-terminal Kinase (JNK) and Protein Kinase C (PKC) interfere, attaching phosphate groups to serine residues instead. This effectively "mutes" the insulin signal.

Mitochondrial Dysfunction and ROS

The mitochondria, the powerhouses of the cell, play a decisive role in this mechanism. When the cell is bombarded with constant glucose and fatty acids, the mitochondrial Electron Transport Chain (ETC) becomes overloaded. This leads to the leakage of electrons, which react with oxygen to form Reactive Oxygen Species (ROS).

These ROS act as biological "alarm signals." To protect itself from further oxidative damage, the cell intentionally induces insulin resistance to prevent more fuel (glucose) from entering an already overwhelmed system. Thus, insulin resistance is not a "broken" mechanism; it is a defensive adaptation by the cell to prevent metabolic "burnout."

##

Environmental Threats and Biological Disruptors

While diet is a primary driver, we must acknowledge the role of Endocrine Disrupting Chemicals (EDCs) and environmental toxins that exacerbate insulin resistance. Modern life in the UK exposes us to a cocktail of substances that interfere with the delicate hormonal balance of the pancreas and the sensitivity of our peripheral tissues.

Bisphenols and Phthalates

Ubiquitous in food packaging and plastic bottles, Bisphenol A (BPA) and its substitutes (BPS/BPF) have been shown to directly stimulate pancreatic beta cells to overproduce insulin. This "insulino-mimetic" effect bypasses the normal glucose-sensing mechanism, leading to chronic hyperinsulinaemia even in the absence of high carbohydrate intake. Phthalates, often found in personal care products and "fragrance" (parfum), interfere with PPAR-gamma receptors, which are critical for healthy fat storage and insulin sensitivity.

Glyphosate and the Gut-Brain Axis

The herbicide Glyphosate, widely used in UK industrial agriculture, disrupts the Shikimate pathway in our gut microbiome. While humans do not have this pathway, our beneficial bacteria do. A dysbiotic gut—cleared of beneficial species like *Akkermansia muciniphila*—leads to an increase in Lipopolysaccharides (LPS) crossing the gut barrier (leaky gut). This triggers systemic "metabolic endotoxaemia," inducing a low-grade inflammatory state that directly promotes insulin resistance in the liver.

The Blue Light Pandemic

Our biological clocks, or Circadian Rhythms, are hardwired to the light-dark cycle. Exposure to artificial blue light from screens after sunset suppresses Melatonin production. Melatonin is not just a sleep hormone; it is a potent antioxidant that protects the pancreatic beta cells. Furthermore, disrupted sleep increases Cortisol, the body’s primary stress hormone, which triggers the liver to dump glucose into the bloodstream via Gluconeogenesis, forcing insulin levels to remain elevated overnight.

##

The Cascade: From Exposure to Disease

The progression from "Normal Blood Sugar/High Insulin" to clinical disease is a relentless cascade that affects every organ system. Because insulin is the master regulator of growth and metabolism, its elevation acts as a systemic "growth signal" that the body cannot turn off.

Step 1: NAFLD and the "Fatty Liver"

The liver is the first stop for nutrients absorbed from the gut. When insulin is high, the liver is forced into a state of permanent Lipogenesis. The accumulation of intra-hepatic fat (Non-Alcoholic Fatty Liver Disease, now termed MASLD) makes the liver resistant to insulin’s signal to stop producing glucose. Now, the liver is pumping out sugar 24/7, even while you sleep, forcing the pancreas to work even harder.

Step 2: Vascular Damage and Hypertension

Mainstream medicine often treats high blood pressure (hypertension) as a salt problem. In reality, it is largely an insulin problem. Insulin causes the kidneys to retain sodium, but more importantly, it stimulates the proliferation of Vascular Smooth Muscle Cells. This thickens the artery walls and reduces the production of Nitric Oxide (NO), the gas responsible for vasodilation. The result is stiff, narrow arteries and high blood pressure—all driven by the "Hidden Marker."

Step 3: Polycystic Ovary Syndrome (PCOS)

In women, the ovaries are highly sensitive to insulin. High levels of insulin stimulate the Theca cells in the ovaries to produce excess testosterone. This disrupts the delicate balance of LH and FSH, leading to anovulation, cysts, and the symptoms of PCOS. Many women are treated with birth control pills (masking the symptoms) when the root cause is metabolic dysfunction that could be identified via a fasting insulin test.

Step 4: The Brain and "Type 3 Diabetes"

Emerging research identifies Alzheimer’s Disease as "Type 3 Diabetes." The brain has its own insulin receptors, and insulin is required for synaptic plasticity and memory formation. However, chronically high peripheral insulin leads to a "downregulation" of the Blood-Brain Barrier’s insulin transporters. The brain becomes starved of energy despite the body being awash in glucose—a state of "starvation amidst plenty" that leads to neurodegeneration.

##

What the Mainstream Narrative Omits

The refusal of health authorities to standardise fasting insulin testing is one of the greatest "omissions" in modern medicine. If fasting insulin is such a powerful predictive marker, why is it not part of the standard NHS "Health Check" for over-40s?

The "Glucocentric" Bias

The medical curriculum is heavily focused on the management of end-stage symptoms. In the "Glucocentric" model, the goal is simply to keep blood sugar down. This leads to the clinical absurdity of treating Type 2 Diabetes—a disease of *too much insulin*—with *more insulin injections*. While this lowers blood sugar (the symptom), it accelerates the underlying disease process, leading to more weight gain, more vascular damage, and more inflammation.

The Pharmaceutical Incentive

There is little profit in identifying a problem that can be solved with fasting, carbohydrate restriction, and walking. Statin drugs, blood pressure medications, and the new wave of GLP-1 agonists (like Semaglutide) represent a multi-billion-pound industry. If the public were empowered to track their HOMA-IR and reverse their insulin resistance through lifestyle before they required these drugs, the financial impact on the pharmaceutical sector would be catastrophic.

The Failure of the "Calorie" Model

Mainstream dietetics still clings to the "Calories In, Calories Out" (CICO) model. This ignores the Endocrine Theory of Obesity. 100 calories of broccoli and 100 calories of fruit juice have the same "energy," but their effect on insulin is worlds apart. By focusing on calories rather than the hormonal response to those calories, the establishment keeps the public on a treadmill of failure, blaming "lack of willpower" for a biological hormonal blockade.

##

The UK Context

In the United Kingdom, the metabolic crisis is reaching a breaking point. The NHS spends approximately £10 billion annually—roughly 10% of its entire budget—on treating Type 2 Diabetes and its complications. Yet, the diagnostic tools used in primary care remain woefully outdated.

The NHS Health Check

The current NHS Health Check uses a QRISK score and an HbA1c test. If your HbA1c is below 42 mmol/mol (6.0%), you are generally told you are fine. However, a significant portion of the British population is "TOFI" (Thin on the Outside, Fat on the Inside). These individuals may have a "normal" BMI and "normal" blood sugar but carry dangerous levels of visceral fat around their organs, driven by high fasting insulin.

The British Diet and the "Eatwell Guide"

The Public Health England (now UKHSA) "Eatwell Guide" continues to recommend that starchy carbohydrates form the base of every meal. For a population that is largely insulin resistant, this advice is biologically disastrous. Recommending cereals, bread, and pasta to someone with hyperinsulinaemia is like throwing petrol on a fire.

Furthermore, the UK's dependence on highly processed "convenience" foods means that the average Briton consumes a massive amount of Refined Seed Oils (Rapeseed, Sunflower, Corn). These oils are high in Linoleic Acid, which accumulates in our fat cells and promotes the production of inflammatory signalling molecules (4-HNE), further driving mitochondrial dysfunction and insulin resistance.

Regulatory Oversight

The Food Standards Agency (FSA) and MHRA have been slow to address the impact of ultra-processed foods (UPFs) on metabolic health. While the "Sugar Tax" was a small step in the right direction, it led to an increase in the use of artificial sweeteners (sucralose, aspartame), which research suggests may still trigger an insulin response via the "cephalic phase" (the brain sensing sweetness and preparing the body for sugar).

##

Protective Measures and Recovery Protocols

The good news is that insulin resistance is not a one-way street. Because it is a dynamic biological adaptation, it can be reversed by changing the signals we send to our cells. To reclaim your health, you must move beyond the "sugar-only" mindset and focus on the "Hidden Marker."

Step 1: Demand the Right Tests

Do not wait for your GP to offer a fasting insulin test—often, you will have to request it specifically or use a private laboratory. To get a complete picture, you need:

• —Fasting Insulin (Optimal: < 5 µU/mL)
• —Fasting Glucose (Optimal: < 4.7 mmol/L)
• —HbA1c (Optimal: < 5.2%)

Step 2: Calculate Your HOMA-IR

Once you have your fasting insulin and glucose, calculate your HOMA-IR index using this formula: *(Fasting Insulin in µU/mL × Fasting Glucose in mmol/L) / 22.5*

• —Optimal: < 1.0
• —Early Insulin Resistance: > 1.9
• —Significant Insulin Resistance: > 2.9

Step 3: Implement Intermittent Fasting (IF)

If insulin resistance is caused by "too much insulin, too often," the cure is "no insulin, for a while." Fasting is the most potent tool for lowering insulin levels. By extending the period between meals, you allow the body to enter a state of Autophagy (cellular cleanup) and force the liver to burn through its stored glycogen, eventually restoring insulin sensitivity. A "16:8" protocol (16 hours fasting, 8 hours eating) is a foundational starting point.

Step 4: Prioritize Protein and Healthy Fats

To keep insulin low, one must reduce the consumption of refined carbohydrates and sugars. Focus on:

• —Bioavailable Protein: Ruminant meat, eggs, and wild-caught fish. Protein has a minimal insulin response compared to carbs.
• —Healthy Fats: Tallow, butter, avocado oil, and extra virgin olive oil. These provide satiety without triggering an insulin spike.
• —Eliminate Seed Oils: Remove all "vegetable" oils (high in linoleic acid) to reduce oxidative stress on the mitochondria.

Step 5: Resistance Training

Skeletal muscle is the largest "glucose sink" in the body. By building muscle through resistance training (lifting weights), you increase the number of GLUT4 transporters and improve the metabolic "drainage" of your bloodstream. Muscle tissue can even take up glucose *without* insulin during and after exercise—a process known as non-insulin-mediated glucose uptake.

Step 6: Targeted Supplementation

While diet is paramount, certain nutrients can "grease the wheels" of metabolic recovery:

• —Magnesium: Essential for the insulin receptor to function. Most Brits are chronically deficient.
• —Chromium & Vanadium: Trace minerals that enhance insulin sensitivity.
• —Berberine: A potent botanical that activates AMPK (the "metabolic master switch"), mimicking some effects of exercise and the drug Metformin.
• —Inositol: Particularly Myo-Inositol, which acts as a secondary messenger in the insulin signalling pathway, especially useful for PCOS.

##

Summary: Key Takeaways

The path to metabolic longevity requires a paradigm shift. We must stop viewing health through the narrow lens of blood sugar and start recognising the hormonal landscape that precedes it.

• —Fasting Insulin is the Lead Indicator: It reveals the "effort" your body is making. High insulin with normal sugar is a red alert, not a clean bill of health.
• —HOMA-IR is the Gold Standard: Use this simple calculation to track your metabolic status at home or with private blood work.
• —Insulin Resistance is a Defence: Your cells are not "broken"; they are protecting themselves from nutrient overload. The solution is to reduce the load, not force more sugar in.
• —Environment Matters: It isn’t just about what you eat. EDCs, blue light, and glyphosate are invisible "metabolic hackers" that must be addressed through lifestyle choices and filtration.
• —The NHS Model is Reactive: You cannot rely on a system designed for "sick care" to provide you with "preventative" excellence. You must be your own researcher and advocate.

At INNERSTANDING, we believe that biological truth is the ultimate form of empowerment. By identifying the "Hidden Marker" of fasting insulin today, you are not just preventing a diagnosis of diabetes tomorrow—you are optimising your energy, your cognitive function, and your long-term vitality. The data is clear; the choice to act upon it is yours.